HOTAIRM1 and Sepsis: By identifying patients who exhibit epigenetic markers of immune suppression, such as the hypermethylation of pro-inflammatory genes or the upregulation of non-coding RNAs like HOTAIRM1, clinicians could tailor treatments to restore immune competence in sepsis survivors.